Welcome to LookChem.com Sign In|Join Free

CAS

  • or
TERT-BUTYL 1,2,2-TRIMETHYLHYDRAZINE-1-CARBOXYLATE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

232615-10-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 232615-10-0 Structure
  • Basic information

    1. Product Name: TERT-BUTYL 1,2,2-TRIMETHYLHYDRAZINE-1-CARBOXYLATE
    2. Synonyms: N,N,N'-TRIMETHYLHYDRAZINE, N'-BOC PROTECTED;TERT-BUTYL 1,2,2-TRIMETHYLHYDRAZINE-1-CARBOXYLATE;tert-butyl 1,2,2-triMethylhydrazinecarboxylate;tert-butyl trimethylhydrazinecarboxylate
    3. CAS NO:232615-10-0
    4. Molecular Formula: C8H18N2O2
    5. Molecular Weight: 174.242
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 232615-10-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 191.136°C at 760 mmHg
    3. Flash Point: 69.397°C
    4. Appearance: /
    5. Density: 0.975g/cm3
    6. Vapor Pressure: 0.523mmHg at 25°C
    7. Refractive Index: 1.453
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: TERT-BUTYL 1,2,2-TRIMETHYLHYDRAZINE-1-CARBOXYLATE(CAS DataBase Reference)
    11. NIST Chemistry Reference: TERT-BUTYL 1,2,2-TRIMETHYLHYDRAZINE-1-CARBOXYLATE(232615-10-0)
    12. EPA Substance Registry System: TERT-BUTYL 1,2,2-TRIMETHYLHYDRAZINE-1-CARBOXYLATE(232615-10-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 232615-10-0(Hazardous Substances Data)

232615-10-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 232615-10-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,2,6,1 and 5 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 232615-10:
(8*2)+(7*3)+(6*2)+(5*6)+(4*1)+(3*5)+(2*1)+(1*0)=100
100 % 10 = 0
So 232615-10-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H18N2O2/c1-8(2,3)12-7(11)10(6)9(4)5/h1-6H3

232615-10-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-(dimethylamino)-N-methylcarbamate

1.2 Other means of identification

Product number -
Other names tert-butyl 1,2,2-trimethylhydrazinecarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:232615-10-0 SDS

232615-10-0Downstream Products

232615-10-0Relevant articles and documents

Synthesis and Properties of Higher Nuclearity Polyazanes

Criton, Thomas,Vilona, Debora,Jacob, Guy,Médebielle, Maurice,Dumont, Elise,Joucla, Lionel,Lac?te, Emmanuel

, p. 3670 - 3674 (2021)

Polyazanes (i.e., higher nuclearity homologues of hydrazines) with increasing numbers of bound nitrogen atoms (from 3 to 5), including the first pentazane ever described, were prepared by the addition of lower-order polyazanes to diazo reagents. A structure was obtained. It was shown that the polynitrogen chains adopt a helical conformation. DFT modeling shows that the arrangement persists in solution. Although the polyazanes are all reducing agents, they become less so as the number of nitrogens increases.

Preparation method of anamorelin intermediate

-

Paragraph 0105; 0106, (2018/07/06)

The invention relates to the field of medicine synthesis, in particular to a preparation method of an anamorelin intermediate. On one hand, 1-boc-1-methylhydrazine is taken as a reaction material, anda key intermediate tert-butyl N,N',N'-trimethylhydrazinecarboxylate is prepared in one pot with a formaldehyde compound and palladium catalyst/hydrogen source alternative reaction method. The methodis simple to operate, and the used raw material is safe and easy to obtain; compared with the prior art, the method has the increased yield; on the other hand, in the method, tert-butyl N,N',N'-trimethylhydrazinecarboxylate and hydrochloric acid are subjected to a reaction in an organic solvent, and a high-yield and high-purity crystallized product of N,N',N'-trimethylhydrazine hydrochloride can be directly obtained, and the crystallized product is not required to be further purified and is low in moisture absorption, convenient to store and very suitable for industrial mass production.

Use of polyanions for alkylation of hydrazine derivatives

Bredihhin, Aleksei,Maeeorg, Uno

, p. 4975 - 4977 (2008/03/28)

Alkylation of hydrazine and its derivatives still remains a quite complicated task. The novel method utilizing the polyanion strategy is reported. Formation and use of trianion for alkylation of hydrazine derivatives is first reported. Described method pr

COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES

-

, (2008/06/13)

Compounds of the general formula I and their use for treating medical disorders resulting from a deficiency in growth hormone.

Growth hormone secretagogues derived from NN703 with hydrazides as C- terminal

Ankersen, Michael,Kramer Nielsen, Karin,Kruse Hansen, Thomas,Raun, Kirsten,Sehested Hansen, Birgit

, p. 487 - 497 (2007/10/03)

A series of GH secretagogues based on modifications in the C-terminal of NN703 is reported. The C-terminal N-methyl amide of NN703 has been replaced with alkylated hydrazides in order to decrease the volume of distribution and identify GH secretagogues with shorter duration of action. Most of the prepared compounds show high potency in a rat pituitary assay. Subsequent to an initial in vivo screening in dogs, four compounds were selected for further pharmacological and pharmacokinetic evaluation. The four compounds showed oral bioavailability around 35% and equipotency in vitro compared to NN703. The relationship between lipophilicity and volume of distribution is discussed and it is speculated whether the lower volume of distribution is attributed to the observed higher in vivo potency and shorter plasma elimination half-life. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

Compounds with growth hormone releasing properties

-

, (2008/06/13)

Compounds of Formula I and their use for treating medical disorders resulting from a deficiency in growth hormone are disclosed, wherein R1, R2, R3a, R4a, R5a, G, J and D are as defined in the specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 232615-10-0